Skip to main content

Table 1 Drug use indicators derived from questionnaire

From: Access to artemisinin combination therapy for malaria in remote areas of Cambodia

Objective of malaria drug policy Indicator
Increase treatment from trained provider % of people with fever who went to a trained provider
Increase use of biological diagnosis % of people with fever who had a biological diagnosis
Reduce delay in treatment % of people who receive modern drugs within 48 hours of symptoms
Correct drug choice % of first-line drug (artesunate and mefloquine) as proportion of modern drugs
Decrease use of artemisinin monotherapy % of artemisinin monotherapy as a proportion of all artemisinin use
Adherence to ACT % of people who take artesunate and mefloquine for at least 3 days
Reduce patient costs Median drug cost of treatment